BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10743804)

  • 21. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
    Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
    Ren Y; Tang J; Mok MY; Chan AW; Wu A; Lau CS
    Arthritis Rheum; 2003 Oct; 48(10):2888-97. PubMed ID: 14558095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SLE--a disease of clearance deficiency?
    Munoz LE; Gaipl US; Franz S; Sheriff A; Voll RE; Kalden JR; Herrmann M
    Rheumatology (Oxford); 2005 Sep; 44(9):1101-7. PubMed ID: 15928001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleosomes in the pathogenesis of systemic lupus erythematosus.
    Koutouzov S; Jeronimo AL; Campos H; Amoura Z
    Rheum Dis Clin North Am; 2004 Aug; 30(3):529-58, ix. PubMed ID: 15261340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?
    Reefman E; de Jong MC; Kuiper H; Jonkman MF; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2006; 8(6):R156. PubMed ID: 17014704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of death-associated molecular patterns in the pathogenesis of systemic lupus erythematosus.
    Mevorach D
    Rheum Dis Clin North Am; 2004 Aug; 30(3):487-504, viii. PubMed ID: 15261338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis, complement and systemic lupus erythematosus: a mechanistic view.
    Liu CC; Navratil JS; Sabatine JM; Ahearn JM
    Curr Dir Autoimmun; 2004; 7():49-86. PubMed ID: 14719375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
    Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
    Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses.
    Adelman MK; Marchalonis JJ
    Clin Immunol; 2002 Feb; 102(2):107-16. PubMed ID: 11846452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the pathogenesis of systemic lupus erythematosus: is complement the villain or the victim?
    Cohen P; Dix D
    J Rheumatol; 1981; 8(4):692-3. PubMed ID: 7299773
    [No Abstract]   [Full Text] [Related]  

  • 31. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
    Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus.
    Rother RP; Mojcik CF; McCroskery EW
    Lupus; 2004; 13(5):328-34. PubMed ID: 15230287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A protective role for innate immunity in systemic lupus erythematosus.
    Carroll MC
    Nat Rev Immunol; 2004 Oct; 4(10):825-31. PubMed ID: 15459673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Exploration of the complement system in clinical practice].
    Frémeaux-Bacchi V; Blouin J; Weiss L
    Arch Pediatr; 1994 Jan; 1(1):71-7. PubMed ID: 8087225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes.
    Reefman E; Kuiper H; Jonkman MF; Limburg PC; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2006 May; 45(5):538-44. PubMed ID: 16352635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on pathogenesis of systemic lupus erythematosus.
    Ahmadpoor P; Dalili N; Rostami M
    Iran J Kidney Dis; 2014 May; 8(3):171-84. PubMed ID: 24878938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement in lupus nephritis: the good, the bad, and the unknown.
    Bao L; Quigg RJ
    Semin Nephrol; 2007 Jan; 27(1):69-80. PubMed ID: 17336690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on complement in the pathogenesis of systemic lupus erythematosus.
    Molina H
    Curr Opin Rheumatol; 2002 Sep; 14(5):492-7. PubMed ID: 12192243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus.
    Holers VM
    Arthritis Rheum; 1999 Oct; 42(10):2023-5. PubMed ID: 10524672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.